Navigation Links
Bottleneck: High on Spirits Can Cause A Dispirited Liver, Leading To Cirrhosis!

If you are hooked on to hooch, or a binge drinker, who is over the board regularly, its time to cork the bottle tight and do something worthwhile to kick the tendency. // Medical experts have issued a wake –up call to the inebriated, that cirrhosis, a disease of the liver is not far away, and is like a ticking time bomb, waiting to explode.

Infact, figures show that there has been an alarming increase of 900% cases of cirrhosis, especially with those under the age of 45, since the year 1970. So, if you are not lily-livered and feel very strongly in your gut, simply kick the habit away!

NHS is deeply concerned with the slackening health figures as much as it is concerned with the huge expenditures that arise due to illnesses. It’s almost like an epidemic, and what is worse for its spread is the Labour’s 24 hour drinking laws, apparently a silent approval for binge drinkers.

The British Society of Gastroenterology has spoken of an increase in alcohol related disease in the coming years. In a statement, the society has expressed “As a nation, we are drinking more than for 90 years and there is a lag between consumption and cirrhosis. Already we have seen a 350 per cent increase in cirrhosis between 1970 and 1998, and this figure is 900 per cent for those under 45 years of age. It is important to anticipate that the burden from alcohol, not only alcoholic liver disease but also alcohol pancreatitis, is going to increase markedly over the coming decade or more."

Professor Elwyn Elias, the society's president and a gastroenterologist based at University Hospital, Birmingham, said "There is a 20 to 30-year lag between what people drink and hospitals filled with the consequences. Binge-drinking can have a sudden effect, but you can also kill yourself in 20 years, by drinking what some people consider a reasonable amount. The evidence is that drinking fell away in the 1930s and 1940s but it's been climbing since the 1960s and
'"/>




Page: 1 2

Related medicine news :

1. Bottleneck: Similac infant formula off the Shelf
2. High Spirits :Second Thoughts on the Mini Pegs
3. Is Diabetes the Leading Cause of Kidney Failure in India
4. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
5. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
6. Breast Cancer Surgery Causes Psychological problems
7. Arthritis Drug May Cause Liver Damage
8. Causes of weakness in the aged
9. Gene Mutation Causes Ovarian Failure
10. Does Radiation Cause Lung Cancer?
11. Chronic Diseases said to Cause Falls in the Elderly
Post Your Comments:
(Date:12/5/2008)... Phyzoom provides physicians a...grow new business. , Colu...nounced today that it has launched Phase I of PHYZ...opment tools. For physicians, PHYZOOM offers nume... including detailed physician and practice profile...
(Date:12/4/2008)...N, Texas, Dec. 4 In the...to convince the world that a Red Ryder BB gun is t... out!" was the response he got from his parents, t...hilarious and memorable quotes from this Christmas...ing our childhood. And unfortunately, it comes tru...
(Date:12/4/2008)...ative research tracking people over a 20-year peri... , , THURSDAY, Dec. 4 (HealthDay News) -...appy friends of your friends. , That,s the unus...d people you,ve never met can have an impact on ea...ess spreads beyond people we,re directly connected...
(Date:12/4/2008)...NGTON, Dec. 4 The U.S. ...nal Development (USAID), is providing an additiona...Zimbabwe. This assistance is in addition to the $... program USAID is already implementing in Zimbabwe... was working alongside the international community...
Breaking Medicine News(10 mins):Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 2Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 3Health News:Texas Parents Can Prevent Holiday Tragedies with Safe Toys and Celebrations 2Health News:Being Happy Affects Even Those You Don't Know 2Health News:Being Happy Affects Even Those You Don't Know 3Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2
...rd researchers suggests a link between the hepatit...study, people who received the vaccine were three-...hree years than those who were not vaccinated. Whi...tigators emphasize the overall effect of the vacci...
... an increased risk for life-threatening cardiovasc...etes would be well // advised to monitor their blo..., according to a new study. Researchers conducted ...ed observational studies focused on the relationsh...
...itis in asthma patients tends to be more severe an...hers suggest patients // can have dramatic improve...surgical options is used. In the study patients wi...cidence of nasal polyps, olfactory dysfunction, an...
... designed to educate parents about allergens and t...in children // say researchers .More than 900 ch... allergic to at least one indoor environmental all...earch shows children who live in these areas suffe...
Other Medicine News:
(Date:12/4/2008)...nist to Advance to Clinical Trials , , SAN ...als, Inc., a biopharmaceutical company focused on ...8) agonists for the treatment of cancer, respirato...t has initiated a Phase I clinical trial of VTX-23...cancer. The multi-center clinical trial is being ...
(Date:12/3/2008)...a demonstrating potential in newly diagnosed patie... featured in two oral sessions at ASH , , -...cally transfused patients by significantly reducin... - New long-term data from major independent breas...surgery treatment strategy, Femara vs. tamoxifen ,...
(Date:12/3/2008)...lleviates long-term anemia and organ damage in mic..., MEMPHIS, Tenn., Dec. 3 /PRNewswire-USNewswire... gene into mouse blood cells, scientists at St. Ju...ckle cell disease pathology. In their studies, the...sentially no difference from normal mice. Although...
(Date:12/3/2008)...Newswire/ -- Isogen, a contract development and,m...ounced it has retained a,strategic financial part...l,biopharma demand for Isogen,s services. , ...st round series of capital,investment and the ope... to,deliver on the previously unmet process, faci...
Breaking Medicine Technology:VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Are Muramyl Peptides the Magic Bullet in Probiotics 3F 1038 1Are Muramyl Peptides the Magic Bullet in Probiotics 3F 1038 2Are Muramyl Peptides the Magic Bullet in Probiotics 3F 1038 3With Obesity Diabetes and Cardiovascular Disease on the Rise Physicians Need More Comprehensive Guidelines 8040 1With Obesity Diabetes and Cardiovascular Disease on the Rise Physicians Need More Comprehensive Guidelines 8040 2SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 1SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 2SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 3SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 4InterCure Names Scot Dube Vice President of Sales 8034 1InterCure Names Scot Dube Vice President of Sales 8034 2InterCure Names Scot Dube Vice President of Sales 8034 3
...rgroupe Francophone du Myelome (IFM),Trial Present...PRNewswire-FirstCall/ --,Millennium Pharmaceutical...d on the comparative Phase III clinical trial eval...multiple myeloma (MM),patients. As induction thera...ELCADE based therapy produced a high complete remi...
...-- Ablynx today announced positive,interim results...pment programme, ALX-0081, an anti-thrombotic trea...cute; therapeutic,Nanobody® targeting von Will...thrombosis in patients with acute coronary,syndrom...signed to assess,safety, tolerability and pharmaco...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Ablynx Announces Interim Results of First Nanobody Phase I Study of,ALX-0081 (ANTI-VWF) 2
Soft PVC. Available in sizes 12-36F, Interior striations for smooth suction catheter insertion. Bevel tip. Single use. Sterile.
Smooth flexible medical grade white low density polyethylene with reinforced block to prevent collapse.
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati
Black elastomer. Smooth finish. Non-Sterile.
Medicine Products: